filings.toolsItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
5K characters. Original on sec.gov · Markdown
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
| --- | --- |
During November 2016 and October 2017, our Board of Directors authorized share repurchase programs, each for up to $2 billion of our outstanding common stock. Repurchases made during the fourth quarter of 2017, as detailed below, were made pursuant to the $2 billion November 2016 (which was completed during the quarter) and the $2 billion October 2017 share repurchase authorizations and were made in the open market.
The following table provides certain information with respect to our repurchases of common stock from October 1, 2017 through December 31, 2017 (dollars in millions, except per share amounts).
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under Publicly Announced Plans or Programs | ||||||||||||
| October 1, 2017 through October 31, 2017 | 2,953,476 | $ | 77.40 | 2,953,476 | $ | 2,150 | ||||||||||
| November 1, 2017 through November 30, 2017 | 2,264,878 | $ | 76.74 | 2,264,878 | $ | 1,976 | ||||||||||
| December 1, 2017 through December 31, 2017 | 2,026,500 | $ | 85.83 | 2,026,500 | $ | 1,802 | ||||||||||
| Total for Fourth Quarter 2017 | 7,244,854 | $ | 79.55 | 7,244,854 | $ | 1,802 | ||||||||||
Our common stock is traded on the New York Stock Exchange (“NYSE”) (symbol “HCA”). There were no dividends or distributions declared during 2017 or 2016. On January 30, 2018, our Board of Directors initiated and declared a quarterly dividend of $0.35 per share on our common stock payable on March 30, 2018 to stockholders of record on March 1, 2018. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors. Our ability to declare future dividends may also from time to time be limited by the terms of our debt agreements.
The table below sets forth, for the calendar quarters indicated, the high and low sales prices per share reported on the NYSE for our common stock.
| Sales Price | ||||||||
| High | Low | |||||||
| 2017 | ||||||||
| First Quarter | $ | 91.03 | $ | 73.52 | ||||
| Second Quarter | 89.80 | 81.10 | ||||||
| Third Quarter | 87.99 | 75.56 | ||||||
| Fourth Quarter | 90.29 | 71.18 | ||||||
| 2016 | ||||||||
| First Quarter | $ | 79.00 | $ | 60.07 | ||||
| Second Quarter | 83.69 | 73.82 | ||||||
| Third Quarter | 81.79 | 73.24 | ||||||
| Fourth Quarter | 82.37 | 67.00 |
At the close of business on February 9, 2018, there were approximately 340 holders of record of our common stock.
Table of Contents
STOCK PERFORMANCE GRAPH
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN
Among HCA Healthcare, Inc., the S&P 500 Index and the S&P Health Care Index
| 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | 12/31/2017 | |||||||||||||||||||
| HCA Healthcare, Inc. | 100.00 | 158.14 | 243.25 | 224.16 | 245.34 | 291.15 | ||||||||||||||||||
| S&P 500 | 100.00 | 132.39 | 150.51 | 152.59 | 170.84 | 208.14 | ||||||||||||||||||
| S&P Health Care | 100.00 | 141.46 | 177.30 | 189.52 | 184.42 | 225.13 |
The graph shows the cumulative total return to our stockholders beginning as of December 31, 2012 through December 31, 2017, in comparison to the cumulative returns of the S&P 500 Index and the S&P Health Care Index. The graph assumes $100 invested on December 31, 2012 in our common stock and in each index with the subsequent reinvestment of dividends. The stock performance shown on the graph represents historical stock performance and is not necessarily indicative of future stock price performance.
Table of Contents
Previous: Item 4. Mine Safety Disclosures · Next: Item 6. Selected Financial Data